Indeed from this, we further denoted the unique biological properties of CD34+ hfDSCs, making it a highly promising potential molecular target for regulating HF senescence with clinical applications towards cell-based approaches for alopecia treatment (Shin et al., 2020). The gene discussed is CD34; the disease is hydrops fetalis.